Page 2 - Codx News Today

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating)’s share price fell 4% on Friday . The stock traded as low as $1.45 and last traded at $1.45. 64,562 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 135,768 shares. The stock had previously closed at $1.51. Analysts Set New Price […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average trading volume of 135,600 shares, the days-to-cover […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average daily trading volume, of 135,600 shares, the short-interest ratio is […]

Co-Diagnostics (NASDAQ:CODX – Get Rating) had its price target lowered by stock analysts at HC Wainwright from $9.00 to $6.00 in a note issued to investors on Monday, The Fly reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 63.04% from the stock’s previous […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 1,850,000 shares, a drop of 17.8% from the May 15th total of 2,250,000 shares. Based on an average trading volume of 402,100 shares, the days-to-cover ratio is currently 4.6 days. Separately, […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,900,000 shares, a growth of 24.2% from the March 15th total of 1,530,000 shares. Based on an average trading volume of 451,800 shares, the short-interest ratio is presently […]

Co-Diagnostics (NASDAQ:CODX – Get Rating) updated its first quarter 2022 earnings guidance on Thursday. The company provided earnings per share guidance of $0.170-$0.200 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.110. The company issued revenue guidance of $21 million-$22 million, compared to the consensus revenue estimate of $21.28 […]

Zacks Investment Research upgraded shares of Co-Diagnostics (NASDAQ:CODX – Get Rating) from a hold rating to a buy rating in a report published on Tuesday, Zacks.com reports. They currently have $7.00 price target on the stock. According to Zacks, “Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics […]

HC Wainwright restated their buy rating on shares of Co-Diagnostics (NASDAQ:CODX – Get Rating) in a report published on Friday morning, TipRanks reports. The firm currently has a $15.00 target price on the stock. A number of other research firms have also recently commented on CODX. Sidoti began coverage on shares of Co-Diagnostics in a […]

Co-Diagnostics (NASDAQ:CODX – Get Rating) issued its quarterly earnings results on Thursday. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.13, Fidelity Earnings reports. Co-Diagnostics had a return on equity of 50.81% and a net margin of 40.11%. During the same quarter last year, the firm […]